Business Description
Sartorius AG
ISIN : DE0007165607
Compare
Compare
Traded in other countries / regions
SRT.Germany0NIR.UKSOAGY.USA1SRT.ItalySRT3.AustriaSRT3.MexicoSRT3.Bulgaria IPO Date
2023-11-13Description
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.14 | |||||
| Equity-to-Asset | 0.27 | |||||
| Debt-to-Equity | 1.7 | |||||
| Debt-to-EBITDA | 5.69 | |||||
| Interest Coverage | 2.09 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.95 | |||||
| Beneish M-Score | -2.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 42.7 | |||||
| 3-Year EBITDA Growth Rate | 40.7 | |||||
| 3-Year EPS without NRI Growth Rate | -13.8 | |||||
| 3-Year FCF Growth Rate | 29.4 | |||||
| 3-Year Book Growth Rate | 26.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 39.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.79 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -6.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.02 | |||||
| Quick Ratio | 1.13 | |||||
| Cash Ratio | 0.63 | |||||
| Days Inventory | 201.35 | |||||
| Days Sales Outstanding | 39.06 | |||||
| Days Payable | 74.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.34 | |||||
| Dividend Payout Ratio | 0.24 | |||||
| 3-Year Dividend Growth Rate | 59.9 | |||||
| Forward Dividend Yield % | 0.34 | |||||
| 5-Year Yield-on-Cost % | 1.08 | |||||
| Shareholder Yield % | -12.81 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.22 | |||||
| Operating Margin % | 13.37 | |||||
| Net Margin % | 5.99 | |||||
| FCF Margin % | 14.41 | |||||
| ROE % | 8.17 | |||||
| ROA % | 1.99 | |||||
| ROIC % | 3.42 | |||||
| ROC (Joel Greenblatt) % | 14.87 | |||||
| ROCE % | 4.53 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 59.15 | |||||
| Forward PE Ratio | 40.18 | |||||
| PE Ratio without NRI | 59.15 | |||||
| Shiller PE Ratio | 46.96 | |||||
| Price-to-Owner-Earnings | 28.01 | |||||
| PEG Ratio | 1.19 | |||||
| PS Ratio | 3.68 | |||||
| PB Ratio | 4.56 | |||||
| Price-to-Free-Cash-Flow | 25.51 | |||||
| Price-to-Operating-Cash-Flow | 13.22 | |||||
| EV-to-EBIT | 46.93 | |||||
| EV-to-Forward-EBIT | 27.02 | |||||
| EV-to-EBITDA | 23.49 | |||||
| EV-to-Forward-EBITDA | 17.21 | |||||
| EV-to-Revenue | 5.62 | |||||
| EV-to-Forward-Revenue | 4.8 | |||||
| EV-to-FCF | 38.74 | |||||
| Price-to-Projected-FCF | 1.97 | |||||
| Price-to-DCF (Earnings Based) | 1.88 | |||||
| Price-to-DCF (FCF Based) | 0.81 | |||||
| Price-to-Median-PS-Value | 0.72 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.48 | |||||
| Earnings Yield (Greenblatt) % | 2.13 | |||||
| FCF Yield % | 3.51 | |||||
| Forward Rate of Return (Yacktman) % | 19.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sartorius AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3,323.7 | ||
| EPS (TTM) (€) | 2.982 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.028982 | ||
| 20-Day SMA (€) | 213 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 211 - 260 | ||
| Shares Outstanding (Mil) | 69.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sartorius AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sartorius AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sartorius AG Frequently Asked Questions
What is Sartorius AG(MIL:1SRT)'s stock price today?
The current price of MIL:1SRT is €213.00. The 52 week high of MIL:1SRT is €260.00 and 52 week low is €211.00.
When is next earnings date of Sartorius AG(MIL:1SRT)?
The next earnings date of Sartorius AG(MIL:1SRT) is 2025-04-18 Est..
Does Sartorius AG(MIL:1SRT) pay dividends? If so, how much?
The Dividend Yield %  of Sartorius AG(MIL:1SRT) is 0.34% (As of Today), Highest Dividend Payout Ratio of Sartorius AG(MIL:1SRT) was 0.61. The lowest was 0.08. And the median was 0.21. The  Forward Dividend Yield % of Sartorius AG(MIL:1SRT) is 0.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers